Keros Therapeutics, Inc. (KROS)
10.98
-1.00
(-8.38%)
USD |
NASDAQ |
May 14, 16:00
10.98
0.00 (0.00%)
After-Hours: 19:04
Keros Therapeutics Market Cap : 216.60M for May 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sarepta Therapeutics, Inc. | 1.971B |
| PTC Therapeutics, Inc. | 6.033B |
| Insmed, Inc. | 25.07B |
| United Therapeutics Corp. | 24.42B |
| Opus Genetics, Inc. | 404.94M |
Market Cap Related Metrics
| PE Ratio | 6.031 |
| PS Ratio | 1.682 |
| Price to Book Value | 0.7145 |
| Price to Free Cash Flow | 3.874 |
| Price | 10.98 |
| Earnings Yield | 16.58% |
| Operating PE Ratio | 6.067 |
| Normalized PE Ratio | 6.024 |